S&P 500   3,841.94
DOW   31,496.30
QQQ   308.68
Black landowner digs in against land grab for oil pipeline
pixel
Opponents suspect environmental racism in pipeline project
GOP pushes bills to allow social media 'censorship' lawsuits
North Macedonia gets first batch of Russia vaccine Sputnik V
pixel
Australia ends defense cooperation with Myanmar over coup
Asian shares mixed after US stimulus bill, profit-taking
Global shares mixed, oil prices up, technology stocks fall
S&P 500   3,841.94
DOW   31,496.30
QQQ   308.68
Black landowner digs in against land grab for oil pipeline
pixel
Opponents suspect environmental racism in pipeline project
GOP pushes bills to allow social media 'censorship' lawsuits
North Macedonia gets first batch of Russia vaccine Sputnik V
pixel
Australia ends defense cooperation with Myanmar over coup
Asian shares mixed after US stimulus bill, profit-taking
Global shares mixed, oil prices up, technology stocks fall
S&P 500   3,841.94
DOW   31,496.30
QQQ   308.68
Black landowner digs in against land grab for oil pipeline
pixel
Opponents suspect environmental racism in pipeline project
GOP pushes bills to allow social media 'censorship' lawsuits
North Macedonia gets first batch of Russia vaccine Sputnik V
pixel
Australia ends defense cooperation with Myanmar over coup
Asian shares mixed after US stimulus bill, profit-taking
Global shares mixed, oil prices up, technology stocks fall
S&P 500   3,841.94
DOW   31,496.30
QQQ   308.68
Black landowner digs in against land grab for oil pipeline
pixel
Opponents suspect environmental racism in pipeline project
GOP pushes bills to allow social media 'censorship' lawsuits
North Macedonia gets first batch of Russia vaccine Sputnik V
pixel
Australia ends defense cooperation with Myanmar over coup
Asian shares mixed after US stimulus bill, profit-taking
Global shares mixed, oil prices up, technology stocks fall
Log in
NASDAQ:CYAN

Cyanotech Stock Forecast, Price & News

$3.64
+0.09 (+2.54 %)
(As of 03/5/2021 12:00 AM ET)
Add
Compare
Today's Range
$3.52
Now: $3.64▼
$3.68
50-Day Range
$3.19
MA: $3.57▼
$3.92
52-Week Range
$1.82
Now: $3.64▼
$3.98
Volume19,700 shs
Average Volume22,695 shs
Market Capitalization$22.19 million
P/E Ratio36.40
Dividend YieldN/A
Beta0.4
Cyanotech Corporation engages in the cultivation, production, and sale of natural products derived from microalgae for the health and human nutrition markets worldwide. The company's products include BioAstin Hawaiian Astaxanthin, a dietary antioxidant, which is used as a human nutraceutical and functional food ingredient to support and maintain the body's natural inflammatory response, enhance skin, and support eye and joint health; and Hawaiian Spirulina Pacifica, a nutrient-rich dietary supplement that is used for extra energy, a strengthened immune system, cardiovascular benefits, and as a source of antioxidant carotenoids. Cyanotech Corporation sells its products as packaged consumer products through distributors, retailers, and online channels, and direct to consumers, as well as in bulk form to manufacturers, formulators, and distributors. The company was founded in 1983 and is headquartered in Kailua-Kona, Hawaii.

Headlines

How Advancements in the food industry is Spurring Growth of Phycocyanin Market: Future Market Insights Report Analyzes
March 4, 2021 |  finance.yahoo.com
Carotenoids Market Share, Development by Companies Outlook, Growth Prospects and Key Opportunities by 2030
March 4, 2021 |  marketwatch.com
Cyanotech Reports Financial Results for the Third Quarter and First Nine Months of Fiscal 2021
February 11, 2021 |  finance.yahoo.com
Astaxanthin Market Segments, Size, Share, Growth Opportunities, Trends, Manufacturers and Global Forecast 2026
February 7, 2021 |  marketwatch.com
Marine Biotechnology Market 2021 Industry Size, Share, Price, Trend and Forecast to 2026
February 4, 2021 |  marketwatch.com
Phytonutrients Market Size Report 2021 | In-Depth Market Analysis and Future Prospects Focusing on Growth Opportunities Till 2025
February 2, 2021 |  marketwatch.com
Astaxanthin Market Growth, Key Players Analysis, Business Opportunities, Global Research Report 2026
January 27, 2021 |  marketwatch.com
Marine Biotechnology Market 2021 to 2025 Growth Factors, Market Characteristics, Opportunities By Type Analysis and Forecast
January 27, 2021 |  marketwatch.com
Pre & Post COVID-19 Market Estimates On Spirulina Market | This Market Worth $629.6 Million by 2025 Grow at a CAGR of 9.4%
January 27, 2021 |  marketwatch.com
Global Microalgae Food Market - Growing Health Awareness, Rising Sustainability towards Plant-based foods driving market growth - by PMI
January 19, 2021 |  marketwatch.com
Marine Algae Products Market | 12 Top Key Players Business Strategies Study Analysis (2022-2031)
January 19, 2021 |  marketwatch.com
Algae Products Market : Exclusive Profitable Comprehensive Report 2020-2030 (COVID-19 UPDATES) | Koninklijke DSM N.V., BASF SE
January 15, 2021 |  marketwatch.com
Algae Protein Market Size, Trends, Companies, Driver, Segmentation, Forecast to 2026
January 6, 2021 |  marketwatch.com
Algae Protein Market Size to Witness Huge Growth by 2027
December 1, 2020 |  marketwatch.com
Global Phytonutrients Market Futuristic Comprehensive Insights with COVID-19 Impact Analysis | BASF SE, Koninklijke DSM N.V.
November 26, 2020 |  marketwatch.com
Cyanotech Corporation's (NASDAQ:CYAN) Stock Has Seen Strong Momentum: Does That Call For Deeper Study Of Its Financial Prospects?
November 16, 2020 |  finance.yahoo.com
Cyanotech Reports Financial Results for the Second Quarter and First Six Months of Fiscal 2021
November 12, 2020 |  finance.yahoo.com
Microalgae-based Aquafeed Market Growth, Size, Demand, Trends, Insights and Forecast 2026
August 18, 2020 |  marketwatch.com
Cyanotech® Corporation Welcomes Charles J. Hartmann as Senior Sales and Marketing Director
July 23, 2020 |  finance.yahoo.com
Nutrex Hawaii® Announces Awareness Program to Inform and Educate Consumers About Their ‘Farm Grown’ Products
June 18, 2020 |  finance.yahoo.com
See More Headlines

Industry, Sector and Symbol

Stock Exchange NASDAQ
Industry Medicinals & botanicals
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:CYAN
Previous Symbol
CUSIPN/A
CIK768408
Webwww.cyanotech.com
Phone808-326-1353
Employees95
Year FoundedN/A

Debt

Debt-to-Equity Ratio0.34
Current Ratio2.10
Quick Ratio0.85

Price-To-Earnings

Trailing P/E Ratio36.40
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual Sales$31.90 million
Price / Sales0.70
Cash Flow$0.52 per share
Price / Cash Flow7.02
Book Value$2.67 per share
Price / Book1.36

Profitability

EPS (Most Recent Fiscal Year)N/A
Net Income$390,000.00
Net Margins1.82%
Return on Equity3.67%
Return on Assets1.80%

Miscellaneous

Outstanding Shares6,097,000
Market Cap$22.19 million
Next Earnings Date6/22/2021 (Estimated)
OptionableNot Optionable

MarketRank™

Overall MarketRank™

0.61 out of 5 stars

Medical Sector

1335th out of 1,968 stocks

Medicinals & Botanicals Industry

17th out of 33 stocks

Analyst Opinion: 0.0Community Rank: 2.4Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.6 5 -4 -3 -2 -1 -
$3.64
+0.09 (+2.54 %)
(As of 03/5/2021 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive CYAN News and Ratings via Email

Sign-up to receive the latest news and ratings for CYAN and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Cyanotech (NASDAQ:CYAN) Frequently Asked Questions

What stocks does MarketBeat like better than Cyanotech?

Wall Street analysts have given Cyanotech a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Cyanotech wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Are investors shorting Cyanotech?

Cyanotech saw a decline in short interest in February. As of February 12th, there was short interest totaling 1,000 shares, a decline of 75.0% from the January 28th total of 4,000 shares. Based on an average daily trading volume, of 25,300 shares, the days-to-cover ratio is currently 0.0 days. Currently, 0.0% of the shares of the stock are short sold.
View Cyanotech's Short Interest.

When is Cyanotech's next earnings date?

Cyanotech is scheduled to release its next quarterly earnings announcement on Tuesday, June 22nd 2021.
View our earnings forecast for Cyanotech.

How were Cyanotech's earnings last quarter?

Cyanotech Co. (NASDAQ:CYAN) announced its quarterly earnings results on Tuesday, August, 11th. The biotechnology company reported $0.02 EPS for the quarter. The biotechnology company earned $7.35 million during the quarter. Cyanotech had a net margin of 1.82% and a trailing twelve-month return on equity of 3.67%.
View Cyanotech's earnings history.

How has Cyanotech's stock price been impacted by COVID-19?

Cyanotech's stock was trading at $1.99 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, CYAN stock has increased by 82.9% and is now trading at $3.64.
View which stocks have been most impacted by COVID-19.

Who are Cyanotech's key executives?

Cyanotech's management team includes the following people:
  • Dr. Gerald R. Cysewski Ph.D., Co-Founder, CEO & Vice Chairman (Age 72, Pay $151.06k)
  • Mr. Glenn D. Jensen, VP of Operations (Age 63, Pay $177.42k)
  • Ms. Felicia I. Ladin, CFO & VP of Fin. & Admin. and Treasurer (Age 49)
  • Mr. Charles J. Hartmann, Sr. Sales & Marketing Director
  • Ms. Amy Beth Nordin, VP of HR & Corp. Sec. (Age 53)

What is Brent D. Bailey's approval rating as Cyanotech's CEO?

4 employees have rated Cyanotech CEO Brent D. Bailey on Glassdoor.com. Brent D. Bailey has an approval rating of 68% among Cyanotech's employees.

Who are some of Cyanotech's key competitors?

Some companies that are related to Cyanotech include Nutra Pharma (NPHC), Happiness Biotech Group (HAPP), Glucose Health (GLUC), True Drinks (TRUU), Mannatech (MTEX), FSD Pharma (HUGE), FitLife Brands (FTLF), Tauriga Sciences (TAUG), Heyu Biological Technology (HYBT), GLG Life Tech (GLGLF), Exactus (EXDI), Entia Biosciences (ERGO), Rock Creek Pharmaceuticals (RCPIQ), Beleave (BE) and Beleave (BE).
View all of CYAN's competitors.

What other stocks do shareholders of Cyanotech own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Cyanotech investors own include Allena Pharmaceuticals (ALNA), Clarivate (CCC), Gilead Sciences (GILD), Madrigal Pharmaceuticals (MDGL), Zynerba Pharmaceuticals (ZYNE), AbbVie (ABBV), AcelRx Pharmaceuticals (ACRX), Amarin (AMRN), Blackrock Resources & Commodities Strategy Trust (BCX) and Bausch Health Companies (BHC).

What is Cyanotech's stock symbol?

Cyanotech trades on the NASDAQ under the ticker symbol "CYAN."

Who are Cyanotech's major shareholders?

Cyanotech's stock is owned by a number of institutional and retail investors. Top institutional investors include Renaissance Technologies LLC (2.99%).
View institutional ownership trends for Cyanotech.

Which major investors are buying Cyanotech stock?

CYAN stock was acquired by a variety of institutional investors in the last quarter, including Renaissance Technologies LLC.
View insider buying and selling activity for Cyanotech or or view top insider-buying stocks.

How do I buy shares of Cyanotech?

Shares of CYAN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Cyanotech's stock price today?

One share of CYAN stock can currently be purchased for approximately $3.64.

How much money does Cyanotech make?

Cyanotech has a market capitalization of $22.19 million and generates $31.90 million in revenue each year.

How many employees does Cyanotech have?

Cyanotech employs 95 workers across the globe.

What is Cyanotech's official website?

The official website for Cyanotech is www.cyanotech.com.

Where are Cyanotech's headquarters?

Cyanotech is headquartered at 73-4460 QUEEN KAAHUMANU HWY SUITE 102, KAILUA KONA HI, 96740.

How can I contact Cyanotech?

Cyanotech's mailing address is 73-4460 QUEEN KAAHUMANU HWY SUITE 102, KAILUA KONA HI, 96740. The biotechnology company can be reached via phone at 808-326-1353 or via email at [email protected]


This page was last updated on 3/8/2021 by MarketBeat.com Staff
Receive Analysts' Upgrades and Downgrades Daily

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.